UK follows North America, French policy on Cypher website warning
This article was originally published in Clinica
Executive Summary
The medical devices section of the Medicines and Healthcare products Regulatory Agency (MHRA) has followed the example of the US, Canadian and French authorities and published on its website a warning concerning the Cypher sirolimus-eluting coronary stent.